Claritev Corporation

Day range

$22.23 – $24.51

Open

$23.85

Prev close

$23.50

Volume

302.86K

Market cap

$398.27M

Shares out

16.95M

P/E

—

P/S

0.40

P/B

-1.35

P/FCF

—

ROE

96.1%

ROA

-5.9%

Debt/Equity

-16.20

Div yield

0.00%

As of Oct 23, 2026

• Director appointmentOct 15, 2026

  On October 15, 2026 (the "Effective Date"), Claritev Corporation (the "Company"), on the recommendation of the Nominating and Corporate Governance Committee of the Company's Board of Directors (the "Board"), increased the size of the Board from eleven (11) to twelve (12) directors. Effective as of the Effective Date, the Board appointed Ms. Jennifer Main to fill the newly created directorship, to serve as a Class II director and a member of the Audit Committee.

• Executive compensation changeSep 15, 2026

  Mr. Letham will receive compensation as a non-employee director in accordance with the Company's non-employee director compensation policy described in the section entitled "Compensation of Directors" of the Company's proxy statement filed with the Securities and Exchange Commission on March 20, 2026, and enter into the Company's standard form indemnification agreement.

• Director departureJul 6, 2026

  On July 6, 2026, Claritev Corporation ("Claritev") was notified of the death of Mr. John Prince. Mr. Prince served as a respected member of the Claritev Board of Directors since June 2023 and served on the Audit Committee at the time of his death.

• Regulatory investigationJun 22, 2026

  On May 19, 2026, the Company received a civil investigative demand from the Antitrust Division and is cooperating fully with the DOJ in responding to the information requested.

• Regulatory investigationMay 18, 2026

  In August of 2024, Claritev Corporation (the "Company") received a confidential grand jury subpoena issued by the Antitrust Division of the Department of Justice ("DOJ") in connection with an investigation regarding health insurance. The Company has been cooperating fully with the DOJ and at no point in the subsequent two years has the DOJ informed the Company that it is the target of an investigation.

Days to cover

5.3

Short interest

978.2K

Avg volume

185.95K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom?
  neutralZacks Investment Research· Oct 9, 2026
• CLARITEV STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is Investigating Claritev Corporation on Behalf of Claritev Stockholders and Encourages Investors to Contact the Firm
  negativeGlobeNewswire Inc.· Jun 2, 2026
• CTEV INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Claritev Corporation
  negativeGlobeNewswire Inc.· May 26, 2026
• Securities Fraud Investigation Into Claritev Corporation (CTEV) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
  negativeBenzinga· May 22, 2026
• Claritev Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
  negativeGlobeNewswire Inc.· Feb 24, 2026